BridgeBio Pharma, Inc. (BBIO)
71.61
+3.08
(+4.49%)
USD |
NASDAQ |
Mar 25, 16:00
71.00
-0.61
(-0.85%)
After-Hours: 20:00
BridgeBio Pharma Free Cash Flow : -455.50M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 9.076B |
| Insmed, Inc. | -997.58M |
| Mirum Pharmaceuticals, Inc. | 54.87M |
| Supernus Pharmaceuticals, Inc. | 45.99M |
| Cogent Biosciences, Inc. | -266.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -56.42M |
| Cash from Investing (Quarterly) | -13.75M |
| Cash from Financing (Quarterly) | -2.782M |
| Free Cash Flow Per Share (Quarterly) | -0.2917 |
| Free Cash Flow to Equity (Quarterly) | -80.71M |
| Free Cash Flow to Firm (Quarterly) | -6.17M |
| Free Cash Flow Yield | -3.32% |